Has Fabian Ortiz received payments from drug or device companies?

Yes. Drug and device makers reported $8,303 in general payments to Fabian Ortiz across 209 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Fabian Ortiz did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Fabian Ortiz come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Fabian Ortiz

Physician Assistant · Bronx, NYNPI 1609511427

Payments from drug & device makers

$8,303in general payments, 2019–2025

Across 209 payments — averaging $39.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
Incyte Corporation$864
Sanofi$668
Lilly USA, LLC$627
Regeneron Healthcare Solutions, Inc.$562
Johnson & Johnson$519
plus $4K from 17 others

What the payments were for

Food & beverage$8,00696%
Education$2974%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	46	$1,055
Incyte Corporation	18	$864
Sanofi	14	$668
Lilly USA, LLC	12	$627
Regeneron Healthcare Solutions, Inc.	17	$562
Johnson & Johnson	4	$519
UCB, Inc.	12	$490
Arcutis Biotherapeutics, Inc.	24	$459
Pfizer	11	$451
LEO Pharma Inc.	11	$428
Janssen Scientific Affairs, LLC	3	$361
Galderma Laboratories, L.p.	10	$317
Journey Medical Corporation	5	$268
AstraZeneca	2	$249
E.r. Squibb & Sons, L.L.C.	2	$234
Novartis	2	$154
Boehringer Ingelheim	2	$139
Smith+Nephew	2	$134
Amgen	6	$127
Dermavant Sciences, Inc.	1	$97
Ortho Dermatologics, A Division Of Bausch Health US, LLC	3	$56
Biohaven Pharmaceutical Holding Company Ltd.	1	$30
Sun Pharmaceutical Industries Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,303 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	33	$121,478
OpzeluraRuxolitinib Phosphate	48	$91,547
VtamaTapinarof	13	$17,825
Tacrolimus	73	$14,708
Clobetasol Propionate	39	$4,003
Hydrocortisone	67	$2,679
Calcipotriene	13	$2,563
Clotrimazole	61	$2,189
Metronidazole	20	$1,793
Clindamycin Phosphate	27	$1,716
Ciclopirox	32	$1,609
Ammonium Lactate	91	$1,556
Triamcinolone Acetonide	147	$1,538
Mometasone Furoate	65	$1,474
Ketoconazole	37	$711

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Incyte CorporationOpzelura	$864	$91,54748 claims
Dermavant Sciences, Inc.Vtama	$97	$17,82513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Bronx

Henry YuBronx$1M
Julius NwosuBronx$256K
George LopezBronx$46K
Kimberley RubinoBronx$29K
Michael AsbachAmherst$962K
Janelle BunceJamestown$565K
Kristyl Cuenca-SiskoNew York$478K
Melissa WhiteGarden City$320K
Lawrence HermanHolbrook$315K
Kaitlyn NelsonBrooklyn$289K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →